Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer’s disease

BACKGROUND: Cognitive improvement has been reported in patients receiving centrally acting angiotensin-converting enzyme inhibitors (C-ACEIs). AIMS: To compare cognitive decline and survival after diagnosis of Alzheimer’s disease between people receiving C-ACEIs, non-centrally acting angiotensin-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Fazal, Karim, Perera, Gayan, Khondoker, Mizanur, Howard, Robert, Stewart, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Psychiatrists 2017
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495996/
https://www.ncbi.nlm.nih.gov/pubmed/28713585
http://dx.doi.org/10.1192/bjpo.bp.116.004184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495996/
https://www.ncbi.nlm.nih.gov/pubmed/28713585
http://dx.doi.org/10.1192/bjpo.bp.116.004184

Ejemplares similares